Health Care Sector Update for 04/16/2019: HUM,JNJ,RARE

Shutterstock photo

Top Health Care Stocks

JNJ +2.25%

PFE -1.35%

ABT +0.37%

MRK -0.13%

AMGN -0.77%

Health care stocks were falling, including a nearly 1.1% decline for the NYSE Health Care Index this afternoon. Shares of health care companies in the S&P 500 also were down almost 1.1% as a group while the Nasdaq Biotechnology index was slipping 0.1%.

Among health care stocks moving on news:

(-) Humana ( HUM ) retreated Tuesday, sinking nearly 7%. The managed care organization earlier said it was engaging physician groups across the country to launch a value-based oncology care program it expects to provide more integrated cancer care for Humana Medicare Advantage and commercial health care insurance members.

In other sector news:

(+) Johnson & Johnson ( JNJ ) was up more than 2% after the health care conglomerate raised its FY19 outlook after Tuesday reporting adjusted Q1 net income of $2.10 per share on $20.02 billion in net sales, topping the Capital IQ consensus by $0.06 per share and $470 million, respectively.

(-) Ultragenyx Pharmaceutical ( RARE ) declined over 4% on Tuesday. The US Food and Drug Administration selected the company's UX007 drug candidate for fast track consideration in addition to granting a pediatric disease designation for the experimental treatment for a group of genetic disorders characterized by the body being unable to convert long-chain fatty acids into energy. Ultragenyx is expecting to file a new drug application for UX007 with the agency by mid-year.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.

This article appears in: Investing , US Markets
Referenced Symbols: HUM , JNJ , RARE

More from MT Newswires


MT Newswires

MT Newswires

Market News, Commodities

Research Brokers before you trade

Want to trade FX?